Wenting Luo

Title: Wenting Luo: Innovator in Antibody-Drug Conjugates

Introduction

Wenting Luo is a prominent inventor based in Yantai, China. He has made significant contributions to the field of biomedicine, particularly in the development of antibody-drug conjugates. With a total of 4 patents, his work focuses on innovative solutions for treating tumors.

Latest Patents

Wenting Luo's latest patents include a "Linker for antibody-drug conjugates and its use." This invention provides a linker designed for preparing antibody-drug conjugates, which are crucial in the treatment of tumors. The linker can couple simultaneously with thiol or amino groups on the antibody or its functional fragments, ensuring a uniform and structurally stable coupled product. Another notable patent is the "Anti-mesothelin antibody and antibody drug conjugate thereof." This invention targets MSLN and includes a method for creating the antibody-drug conjugate, along with a novel MSLN antibody featuring engineered heavy and light chains.

Career Highlights

Wenting Luo has worked with notable companies such as Remegen Co., Ltd. and Remegen, Ltd. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative medical solutions.

Collaborations

Wenting has collaborated with esteemed colleagues, including Changjiang Huang and Hui Ye, who is a woman. These collaborations have further enriched his research and development efforts in the field of antibody-drug conjugates.

Conclusion

Wenting Luo's innovative work in the field of antibody-drug conjugates showcases his commitment to advancing medical treatments for tumors. His patents reflect a deep understanding of biomedicine and a dedication to improving patient outcomes.